BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 29078772)

  • 1. Canadian Men's perspectives about active surveillance in prostate cancer: need for guidance and resources.
    Fitch M; Pang K; Ouellet V; Loiselle C; Alibhai S; Chevalier S; Drachenberg DE; Finelli A; Lattouf JB; Sutcliffe S; So A; Tanguay S; Saad F; Mes-Masson AM
    BMC Urol; 2017 Oct; 17(1):98. PubMed ID: 29078772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 'What is this active surveillance thing?' Men's and partners' reactions to treatment decision making for prostate cancer when active surveillance is the recommended treatment option.
    O'Callaghan C; Dryden T; Hyatt A; Brooker J; Burney S; Wootten AC; White A; Frydenberg M; Murphy D; Williams S; Schofield P
    Psychooncology; 2014 Dec; 23(12):1391-8. PubMed ID: 24830805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Describing perspectives of health care professionals on active surveillance for the management of prostate cancer.
    Pang K; Fitch M; Ouellet V; Chevalier S; Drachenberg DE; Finelli A; Lattouf JB; So A; Sutcliffe S; Tanguay S; Saad F; Mes-Masson AM
    BMC Health Serv Res; 2018 Jun; 18(1):430. PubMed ID: 29884180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors influencing men undertaking active surveillance for the management of low-risk prostate cancer.
    Davison BJ; Oliffe JL; Pickles T; Mroz L
    Oncol Nurs Forum; 2009 Jan; 36(1):89-96. PubMed ID: 19136342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Active surveillance for low-risk localized prostate cancer: what do men and their partners think?
    Mallapareddi A; Ruterbusch J; Reamer E; Eggly S; Xu J
    Fam Pract; 2017 Feb; 34(1):90-97. PubMed ID: 28034917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presenting treatment options to men with clinically localized prostate cancer: the acceptability of active surveillance/monitoring.
    Donovan JL
    J Natl Cancer Inst Monogr; 2012 Dec; 2012(45):191-6. PubMed ID: 23271772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient acceptance of active surveillance as a treatment option for low-risk prostate cancer.
    Davison BJ; Goldenberg SL
    BJU Int; 2011 Dec; 108(11):1787-93. PubMed ID: 21507187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is 'watchful waiting' a real choice for men with prostate cancer? A qualitative study.
    Chapple A; Ziebland S; Herxheimer A; McPherson A; Shepperd S; Miller R
    BJU Int; 2002 Aug; 90(3):257-64. PubMed ID: 12133062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Active Surveillance for Prostate Cancer: How to Do It Right.
    Garisto JD; Klotz L
    Oncology (Williston Park); 2017 May; 31(5):333-40, 345. PubMed ID: 28512731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population-based assessment of determining predictors for quality of prostate cancer surveillance.
    Chamie K; Williams SB; Hershman DL; Wright JD; Nguyen PL; Hu JC
    Cancer; 2015 Dec; 121(23):4150-7. PubMed ID: 26307939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors associated with treatment received by men diagnosed with prostate cancer in Queensland, Australia.
    Baade PD; Youlden DR; Gardiner RA; Ferguson M; Aitken JF; Yaxley J; Chambers SK
    BJU Int; 2012 Dec; 110(11 Pt B):E712-9. PubMed ID: 23017157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 'It's not like you just had a heart attack': decision-making about active surveillance by men with localized prostate cancer.
    Volk RJ; McFall SL; Cantor SB; Byrd TL; Le YC; Kuban DA; Mullen PD
    Psychooncology; 2014 Apr; 23(4):467-72. PubMed ID: 24243777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient Factors That Influence How Physicians Discuss Active Surveillance With Low-Risk Prostate Cancer Patients: A Qualitative Study.
    Brooks JV; Ellis SD; Morrow E; Kimminau KS; Thrasher JB
    Am J Mens Health; 2018 Sep; 12(5):1719-1727. PubMed ID: 29973123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate Cancer in Elderly Men: Screening, Active Surveillance, and Definitive Therapy.
    Roussel B; Ouellet GM; Mohile SG; Dale W
    Clin Geriatr Med; 2015 Nov; 31(4):615-29. PubMed ID: 26476120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Qualitative insights into how men with low-risk prostate cancer choosing active surveillance negotiate stress and uncertainty.
    Mader EM; Li HH; Lyons KD; Morley CP; Formica MK; Perrapato SD; Irwin BH; Seigne JD; Hyams ES; Mosher T; Hegel MT; Stewart TM
    BMC Urol; 2017 May; 17(1):35. PubMed ID: 28482875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uncertainty and quality of life among men undergoing active surveillance for prostate cancer in the United States and Ireland.
    Hegarty JM; Wallace M; Comber H
    Am J Mens Health; 2008 Jun; 2(2):133-42. PubMed ID: 19477777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Connections Between Work, Prostate Cancer Screening, Diagnosis, and the Decision to Undergo Radical Prostatectomy.
    Yu Ko WF; Oliffe JL; Johnson JL; Bottorff JL
    Am J Mens Health; 2018 Sep; 12(5):1670-1680. PubMed ID: 29938564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Designing Normative Messages About Active Surveillance for Men With Localized Prostate Cancer.
    Volk RJ; Kinsman GT; Le YC; Swank P; Blumenthal-Barby J; McFall SL; Byrd TL; Mullen PD; Cantor SB
    J Health Commun; 2015; 20(9):1014-20. PubMed ID: 26066011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. This is an older men's world: A qualitative study of men's experiences with prostate cancer.
    van Ee IB; Hagedoorn M; Smits CHM; Kamper AM; Honkoop HA; Slaets JPJ
    Eur J Oncol Nurs; 2018 Dec; 37():56-64. PubMed ID: 30473052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decision-Making in Prostate Cancer: Active Surveillance Over Other Treatment Options.
    Bayliss D; Duff J; Stricker P; Walker K
    Urol Nurs; 2016; 36(3):141-9. PubMed ID: 27501595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.